Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
PETROCHINA
00857
5
SINOPEC CORP
00386
No Data
Precision BioSciences Exits Substantial Shareholder Role in Imugene
Imugene Restructures Convertible Notes and Raises New Capital for Oncology Trials
Imugene Cancels 175 Convertible Notes by Mutual Agreement
Imugene Seeks ASX Quotation for 12.5 Million New Shares
Imugene Plans Warrant and Convertible Note Issue to Fund Growth
Imugene Seeks ASX Quotation for New Tranche of 2027 Options